Skip to main content

Animations

MJFF Publications

301 - 310 of 6458 Results
Title
Year
  • Year
  • 2015
  • 2016
  • 2010
  • 2012
  • 2012
  • 2014
  • 2009
  • 2008
  • 2010
  • 2014
  • Summary Details
    OPEN
    Title: Can Parkinson’s disease be cured by stimulating neurogenesis?
    Journal Name: Journal of Clinical Investigation
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1172/jci80822
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Clinical signs in functional (psychogenic) gait disorders: a brief survey
    Journal Name: Journal of Clinical Movement Disorders
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40734-016-0031-1
    Citation Count: 23
  • Summary Details
    OPEN
    Title: A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ncomms1085
    Citation Count: 155
  • Summary Details
    OPEN
    Title: Alternative α-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ncomms2032
    Citation Count: 145
  • Summary Details
    OPEN
    Title: Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ncomms1669
    Citation Count: 252
  • Summary Details
    OPEN
    Title: Archaerhodopsin variants with enhanced voltage-sensitive fluorescence in mammalian and Caenorhabditis elegans neurons
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ncomms5894
    Citation Count: 144
  • Summary Details
    OPEN
    Title: α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ng.300
    Best OA location URL: http://doi.org/10.1038/ng.300
    Citation Count: 537
  • Summary Details
    OPEN
    Title: Therapeutic cloning in individual parkinsonian mice
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nm1732
    Citation Count: 116
  • Summary Details
    OPEN
    Title: Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nm.2199
    Citation Count: 382
  • Summary Details
    OPEN
    Title: MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ncomms4633
    Citation Count: 334
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.